PGI11 Cost-Effectiveness Analysis of Tofacitinib in the Treatment of Ulcerative Colitis in the Perspective of Brazilian Public Healthcare System

Public Healthcare ◽

Can hydrophilic coated catheters be beneficial for the public healthcare system in Brazil? - A cost-effectiveness analysis in patients with spinal cord injuries

International braz j urol ◽

10.1590/s1677-5538.ibju.2017.0221 ◽

2018 ◽

Vol 44 (1) ◽

pp. 121-131 ◽

Cited By ~ 3

Author(s):

José Carlos Truzzi ◽

Vanessa Teich ◽

Camila Pepe

Keyword(s):

Spinal Cord ◽

Cost Effectiveness ◽

Healthcare System ◽

Spinal Cord Injuries ◽

Public Healthcare ◽

The Public ◽

Cost-Effectiveness Analysis Of 52 Mg Levonorgestrel-Releasing Intrauterine System (Lng-Ius) Versus Short-Acting Hormonal Contraceptives In Avoiding Unintended Pregnancy (Up) In 15 To 19 Year-Old Adolescents Under The Brazilian Public Healthcare System (Sus)

Value in Health ◽

10.1016/j.jval.2016.09.322 ◽

2016 ◽

Vol 19 (7) ◽

pp. A402

Author(s):

A Honda ◽

NB Ramos ◽

M Sakagute ◽

C Nakada ◽

F Tobaruella

Keyword(s):

Cost Effectiveness ◽

Healthcare System ◽

Unintended Pregnancy ◽

Hormonal Contraceptives ◽

Public Healthcare ◽

Short Acting ◽

PSS25 - COST-EFFECTIVENESS ANALYSIS OF INTRAVITREAL AFLIBERCEPT VERSUS RANIBIZUMAB IN THE TREATMENT OF DIABETIC MACULAR EDEMA (DME) UNDER THE BRAZILIAN PUBLIC HEALTHCARE SYSTEM (SUS)

Value in Health ◽

10.1016/j.jval.2018.09.2525 ◽

2018 ◽

Vol 21 ◽

pp. S426

Author(s):

M.P. Rosim ◽

B.S. Riveros ◽

H.S. Kim ◽

C. Nakada ◽

W.R. Freire

Keyword(s):

Cost Effectiveness ◽

Macular Edema ◽

Diabetic Macular Edema ◽

Healthcare System ◽

Public Healthcare ◽

Effectiveness Analysis ◽

Intravitreal Aflibercept

Cost-Effectiveness Analysis of Obinutuzumab Associated to Chlorambucil for the Treatment of Slow-Go Patients with Chronic Lymphocytic Leukemia (CLL) Under the Brazilian Public Healthcare System

Value in Health ◽

10.1016/j.jval.2017.08.2443 ◽

2017 ◽

Vol 20 (9) ◽

pp. A855

Author(s):

R Ho ◽

C Rufino ◽

J Biondo ◽

M Alves

Keyword(s):

Cost Effectiveness ◽

Chronic Lymphocytic Leukemia ◽

Healthcare System ◽

Lymphocytic Leukemia ◽

Public Healthcare ◽

PRO38 COST-EFFECTIVENESS ANALYSIS OF EMICIZUMAB VERSUS BYPASSING AGENTS IN PATIENTS WITH HEMOPHILIA A WITH INHIBITORS IN THE BRAZILIAN PUBLIC HEALTHCARE SYSTEM PERSPECTIVE

Value in Health ◽

10.1016/j.jval.2019.09.2368 ◽

2019 ◽

Vol 22 ◽

pp. S847

Author(s):

P. Souza ◽

G.R. Puopolo ◽

R. Leme-Souza

Keyword(s):

Cost Effectiveness ◽

Healthcare System ◽

Hemophilia A ◽

Public Healthcare ◽

System Perspective ◽

Healthcare System Perspective ◽

Effectiveness Analysis ◽

Bypassing Agents

Performing a cost-effectiveness analysis: surveillance of patients with ulcerative colitis

The American Journal of Gastroenterology ◽

10.1111/j.1572-0241.1998.00314.x ◽

1998 ◽

Vol 93 (6) ◽

pp. 872-880 ◽

Cited By ~ 55

Author(s):

Dawn Provenzale ◽

John B. Wong ◽

Jane E. Onken ◽

Joseph Lipscomb

Keyword(s):

Ulcerative Colitis ◽

Cost Effectiveness ◽

A Cost-Effectiveness Analysis of Tacrolimus XL in Comparison to Generic Tacrolimus from the Public Healthcare Sector in Mexico

Value in Health ◽

10.1016/j.jval.2017.08.2727 ◽

2017 ◽

Vol 20 (9) ◽

pp. A896

Author(s):

P Anaya ◽

JA de Anda ◽

A Salazar ◽

S Braun

Keyword(s):

Cost Effectiveness ◽

Healthcare Sector ◽

Public Healthcare ◽

The Public ◽

Effectiveness Analysis ◽

Public Healthcare Sector

PCN25 COST-EFFECTIVENESS OF NIVOLUMAB IN FIRST-LINE TREATMENT OF ADVANCED MELANOMA REGARDLESS OF BRAF MUTATION STATUS FROM A BRAZILIAN PUBLIC HEALTHCARE SYSTEM

Value in Health Regional Issues ◽

10.1016/j.vhri.2019.08.093 ◽

2019 ◽

Vol 19 ◽

pp. S17-S18

Author(s):

J.P.D.S.N. Lima ◽

P. Marinheiro ◽

G. Bernardino

Keyword(s):

Cost Effectiveness ◽

Healthcare System ◽

Braf Mutation ◽

Advanced Melanoma ◽

Public Healthcare ◽

Line Treatment ◽

First Line ◽

Mutation Status ◽

First Line Treatment

Cost-effectiveness analysis of the SP142 versus 22C3 PD-L1 assays in the treatment of atezolizumab plus nab-paclitaxel for patients with advanced triple negative breast cancer in the Brazilian private healthcare system

Journal of Medical Economics ◽

10.1080/13696998.2020.1821039 ◽

2020 ◽

Vol 23 (11) ◽

pp. 1340-1344

Author(s):

Rodrigo Shimabukuro Ho ◽

Mariana Mioti Sebastião ◽

João Paulo Venezian de Carvalho ◽

Tomás Neves ◽

Micha Nussbaum

Keyword(s):

Breast Cancer ◽

Cost Effectiveness ◽

Healthcare System ◽

Triple Negative Breast Cancer ◽

Triple Negative ◽

Private Healthcare ◽

Long-Term Cost-Effectiveness Analysis of Infliximab in the Management of Ulcerative Colitis

Gastroenterology ◽

10.1016/s0016-5085(11)60813-5 ◽

2011 ◽

Vol 140 (5) ◽

pp. S-201 ◽

Cited By ~ 1

Author(s):

Victoria Ung ◽

Thomas W. Lee ◽

Haili Wang ◽

Karen I. Kroeker ◽

Thanh X. Nguyen ◽

...

Keyword(s):

Ulcerative Colitis ◽

Cost Effectiveness ◽